Interferon beta-1a

Pharmaceutical drug

Last price

—

Floor price

—

7-day median

—

30-day sales

30-day range

—

In circulation

Price history

Show table

Date	median	Low	High	sales

Sales history

Last sale: —
30-day average: —
30-day low: —
30-day high: —
Sales 7d: 0
Sales 30d: 0

No sales yet.

Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.

From Wikipedia

Interferon beta-1a (also interferon beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS). It is produced by mammalian cells, while interferon beta-1b is produced in modified E. coli. Some research indicates that interferon injections may result in an 18–38% reduction in the rate of MS relapses. Interferon beta has not been shown to slow the advance of disability. Interferons are not a cure for MS (there is no known cure); the claim is that interferons may slow the progress of the disease if started early and continued for the duration of the disease.

Text: Wikipédia, CC BY-SA 4.0. · Image: Nevit Dilmen (CC BY-SA 3.0) ·